The publication of BrainCool AB’s quarterly report for Q1 2024 will be brought forward to today, April 15, 2024. The previously announced date for publication was May 2, 2024. The reason why the publication of the quarterly report is brought forward is that the report has been finalized earlier as part of the preparations for the planned financing that was announced on March 24, 2024.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

Attachments
BrainCool AB (publ): Publication of the quarterly report for Q1 will be brought forward to today, April 15, 2024

© Modular Finance, source Nordic Press Releases